Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 18Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Stomach Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Cancer 1Sarcoma 1Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Laryngeal Neoplasms 1Kidney Neoplasms 1Invasive Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1

Interventions

trastuzumab deruxtecan 1toripalimab 1pertuzumab 1pembrolizumab 1atezolizumab 1Trastuzumab 1Ramucirumab 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Etoposide 1Cetuximab 1Carboplatin 1Capecitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Solid Cancer × Albumin-Bound Paclitaxel × Clear all
NCT06771622 2026-02-04

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

FBD Biologics Limited

Phase 1/2 Active not recruiting
500 enrolled

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡